IDEXX Laboratories, Inc. operates in a vast healthcare market, developing cutting-edge diagnostic products for animals and water testing. With a stable presence globally, the company's diverse market segments might provide opportunities for steady growth despite market volatility.
IDEXX Laboratories holds a solid fundamental position, reflected by its strengths in Return on Equity and Return on Assets.
| Category | Score | Visualization |
|---|---|---|
| DCF | 3 | |
| ROE | 5 | |
| ROA | 5 | |
| Debt to Equity | 1 | |
| P/E | 1 | |
| P/B | 1 |
Analysis of past performance shows consistency in key financial metrics, which might indicate stability.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-21 | 3 | 3 | 5 | 5 | 1 | 1 | 1 |
| N/A | 0 | 3 | 5 | 5 | 1 | 1 | 1 |
Analyst predictions suggest a bullish outlook with significant potential upside, as reflected in the high target price.
| High | Low | Median | Consensus |
|---|---|---|---|
| 785 | 640 | 722 | 715.67 |
The consensus among analysts indicates a Buy recommendation, dominated by Buy ratings.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 11 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
IDEXX Laboratories presents a promising investment opportunity given its strong positioning and consistent fundamental performance. The company’s dedication to innovation in the healthcare diagnostics sector solidifies its potential for long-term growth. However, investors should be mindful of market volatility and economic changes, which might affect future performance. Analyst sentiments underscore a robust outlook, suggesting potential upside in price targets. Overall, the stock appears to offer a balanced risk-reward proposition for informed investors.